|
1
|
Martín-Cleary C and Ortiz A: CKD hotspots
around the world: Where, why and what the lessons are. A CKJ review
series. Clin Kidney J. 7:519–523. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liyanage T, Ninomiya T, Jha V, Neal B,
Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, et al:
Worldwide access to treatment for end-stage kidney disease: A
systematic review. Lancet. 385:1975–1982. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Duffield JS: Cellular and molecular
mechanisms in kidney fibrosis. J Clin Invest. 124:2299–22306. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aihara K, Ikeda Y, Yagi S, Akaike M and
Matsumoto T: Transforming growth factor-β1 as a common target
molecule for development of cardiovascular diseases, renal
insufficiency and metabolic syndrome. Cardiol Res Pract.
2011:1753812010.PubMed/NCBI
|
|
5
|
Herrera GA, Turbat-Herrera EA and Teng J:
Mesangial homeostasis and pathobiology: Their role in health and
disease. Contrib Nephrol. 169:6–22. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kawakami T, Ren S and Duffield JS: Wnt
signalling in kidney diseases: Dual roles in renal injury and
repair. J Pathol. 229:221–231. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barker N: The canonical Wnt/beta-catenin
signaling pathway. Methods Mol Biol. 468:5–15. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kikuchi A, Yamamoto H, Sato A and
Matsumoto S: New insights into the mechanism of Wnt signaling
pathway activation. Int Rev Cell Mol Biol. 291:21–71. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Macdonald BT, Semenov MV and He X:
SnapShot: Wnt/beta-catenin signaling. Cell. 131:12042007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
He W, Dai C, Li Y, Zeng G, Monga SP and
Liu Y: Wnt/beta-catenin signaling promotes renal interstitial
fibrosis. J Am Soc Nephrol. 20:765–776. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He W, Tan RJ, Li Y, Wang D, Nie J, Hou FF
and Liu Y: Matrix metalloproteinase-7 as a surrogate marker
predicts renal Wnt/β-catenin activity in CKD. J Am Soc Nephrol.
23:294–304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Z, Xu J, Xu P, Liu S and Yang Z:
Wnt/β-catenin signalling pathway mediates high glucose induced cell
injury through activation of TRPC6 in podocytes. Cell Prolif.
46:76–85. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dai C, Stolz DB, Kiss LP, Monga SP,
Holzman LB and Liu Y: Wnt/beta-catenin signaling promotes podocyte
dysfunction and albuminuria. J Am Soc Nephrol. 20:1997–2008. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Heikkilä E, Juhila J, Lassila M, Messing
M, Perälä N, Lehtonen E, Lehtonen S, Verbeek Sjef J and Holthofer
H: beta-Catenin mediates adriamycin-induced albuminuria and
podocyte injury in adult mouse kidneys. Nephrol Dial Transplant.
25:2437–2446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin CL, Wang JY, Huang YT, Kuo YH,
Surendran K and Wang FS: Wnt/beta-catenin signaling modulates
survival of high glucose-stressed mesangial cells. J Am Soc
Nephrol. 17:2812–2820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lin CL, Cheng H, Tung CW, Huang WJ, Chang
PJ, Yang JT and Wang JY: Simvastatin reverses high glucose-induced
apoptosis of mesangial cells via modulation of Wnt signaling
pathway. Am J Nephrol. 28:290–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Akhmetshina A, Palumbo K, Dees C, Bergmann
C, Venalis P, Zerr P, Horn A, Kireva T, Beyer C, Zwerina J, et al:
Activation of canonical Wnt signalling is required for
TGF-β-mediated fibrosis. Nat Commun. 3:7352012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ho C, Lee PH, Hsu YC, Wang FS, Huang YT
and Lin CL: Sustained Wnt/β-catenin signaling rescues high glucose
induction of transforming growth factor-β1-mediated renal fibrosis.
Am J Med Sci. 344:374–382. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhan YL and Dai XW: Treatment of 30 cases
with chronic nephritis with Yiqihuoxuejiedu formula. Zhong Yi Yao
Tong Bao. 44:922 9242003.(In Chinese).
|
|
20
|
Zhan YL, Dai XW, Li XY, Li S and Rao XR:
Renal protective effect of Yiqiqingre extract on adriamycin induced
nephropathy. Chin West Med. 4:135 1382003.(In Chinese).
|
|
21
|
Zhan Y, Yang L, Wen Y, Liu H, Zhang H, Zhu
B, Han W, Gu Y, Sun X, Dong X, et al: Yi qi qing re gao attenuates
podocyte injury and inhibits vascular endothelial growth factor
overexpression in puromycin aminonucleoside rat model. Evid Based
Complement Alternat Med. 2014:3759862014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zu N, Li P, Li N, Choy P and Gong Y:
Mechanism of saikosaponin-d in the regulation of rat mesangial cell
proliferation and synthesis of extracellular matrix proteins.
Biochem Cell Biol. 85:169–174. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Migliorini A, Ebid R, Scherbaum CR and
Anders HJ: The danger control concept in kidney disease: Mesangial
cells. J Nephrol. 26:437–449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhou D, Li Y, Lin L, Zhou L, Igarashi P
and Liu Y: Tubule-specific ablation of endogenous β-catenin
aggravates acute kidney injury in mice. Kidney Int. 82:537–547.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin CL, Wang JY, Ko JY, Surendran K, Huang
YT, Kuo YH and Wang FS: Superoxide destabilization of beta-catenin
augments apoptosis of high-glucose-stressed mesangial cells.
Endocrinology. 149:2934–2942. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin CL, Wang JY, Ko JY, Huang YT, Kuo YH
and Wang FS: Dickkopf-1 promotes hyperglycemia-induced accumulation
of mesangial matrix and renal dysfunction. J Am Soc Nephrol.
21:124–135. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Villa L, Boor P, Konieczny A, Kunter U,
van Roeyen CR, Denecke B, Gan L, Kupper MB, Hoffmann K, Eitner F,
et al: Effects and mechanisms of angiotensin II receptor blockade
with telmisartan in a normotensive model of mesangioproliferative
nephritis. Nephrol Dial Transplant. 26:3131–3143. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tveita AA and Rekvig OP: Alterations in
Wnt pathway activity in mouse serum and kidneys during lupus
development. Arthritis Rheum. 63:513–522. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
López-Hernández FJ and López-Novoa JM:
Role of TGF-β in chronic kidney disease: An integration of tubular,
glomerular and vascular effects. Cell Tissue Res. 347:141–154.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee HS and Song CY: Differential role of
mesangial cells and podocytes in TGF-beta-induced mesangial matrix
synthesis in chronic glomerular disease. Histol Histopathol.
24:901–908. 2009.PubMed/NCBI
|
|
31
|
Zhang P, Cai Y, Soofi A and Dressler GR:
Activation of Wnt11 by transforming growth factor-β drives
mesenchymal gene expression through non-canonical Wnt protein
signaling in renal epithelial cells. J Biol Chem. 287:21290–21302.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang L, Chi YF, Yuan ZT, Zhou WC, Yin PH,
Zhang XM, Peng W and Cai H: Astragaloside IV inhibits renal
tubulointerstitial fibrosis by blocking TGF-β/Smad signaling
pathway in vivo and in vitro. Exp Biol Med (Maywood).
239:1310–1324. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Meng LQ, Tang JW, Wang Y, Zhao JR, Shang
MY, Zhang M, Liu SY, Qu L, Cai SQ and Li XM: Astragaloside IV
synergizes with ferulic acid to inhibit renal tubulointerstitial
fibrosis in rats with obstructive nephropathy. Br J Pharmacol.
162:1805–1818. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yongping M, Zhang X, Xuewei L, Fan W, Chen
J, Zhang H, Chen G, Liu C and Liu P: Astragaloside prevents
BDL-induced liver fibrosis through inhibition of notch signaling
activation. J Ethnopharmacol. 169:200–209. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li YH, Zheng FJ, Huang Y, Zhong XG and Guo
MZ: Synergistic anti-inflammatory effect of Radix Platycodon
in combination with herbs for cleaning-heat and detoxification and
its mechanism. Chin J Integr Med. 19:29–35. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cheng H, Bo Y, Shen W, Tan J, Jia Z, Xu C
and Li F: Leonurine ameliorates kidney fibrosis via suppressing
TGF-β and NF-κB signaling pathway in UUO mice. Int Imunopharmacol.
25:406–415. 2015. View Article : Google Scholar
|
